UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC

Neoplasia (New York, N.Y.), 2017-12, Vol.19 (12), p.1012-1021

2017

Volltextzugriff (PDF)

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)

Hepatology (Baltimore, Md.), 2014-01, Vol.59 (1), p.228-241

2014

Volltextzugriff (PDF)

MicroRNAs Impair MET-Mediated Invasive Growth

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (24), p.10128-10136

2008

Volltextzugriff (PDF)

Multitarget drugs: the present and the future of cancer therapy

Expert opinion on pharmacotherapy, 2009-03, Vol.10 (4), p.589-600

2009

Volltextzugriff (PDF)

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (13), p.5090-5095

2006

Volltextzugriff (PDF)

Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis

Molecular biology of the cell, 2009-05, Vol.20 (9), p.2495-2507

2009

Volltextzugriff (PDF)

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

Cells (Basel, Switzerland), 2022-06, Vol.11 (12), p.1944

2022

Volltextzugriff (PDF)

TGFα expression impairs Trastuzumab-induced HER2 downregulation

Oncogene, 2005-04, Vol.24 (18), p.3002-3010

2005

Volltextzugriff (PDF)

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis

Oncotarget, 2017-02, Vol.8 (9), p.15716-15731

2017

Volltextzugriff (PDF)

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

ESMO open, 2020-10, Vol.5 (5), p.e000937-e000937, Article e000937

2020

Volltextzugriff (PDF)

From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage

Current medicinal chemistry, 2008-02, Vol.15 (5), p.422-432

2008

Volltextzugriff (PDF)

Genome editing of a recalcitrant wine grape genotype by lipofectamine‐mediated delivery of CRISPR/Cas9 ribonucleoproteins to protoplasts

The Plant journal : for cell and molecular biology, 2024-07, Vol.119 (1), p.404-412

2024

Volltextzugriff (PDF)

The SH3 Domains of Endophilin and Amphiphysin Bind to the Proline-rich Region of Synaptojanin 1 at Distinct Sites That Display an Unconventional Binding Specificity

The Journal of biological chemistry, 1999-11, Vol.274 (45), p.32001-32007

1999

Volltextzugriff (PDF)

Nrf2, but not [beta]-catenin, mutation represents an early event in rat hepatocarcinogenesis

Hepatology (Baltimore, Md.), 2015-09, Vol.62 (3), p.851

2015

Volltextzugriff (PDF)

Identification of a subpopulation of patients with gastric cancer responsive to PARP inhibitors

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.432-432

2023

Volltextzugriff (PDF)

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

Journal of hepatology, 2020-06, Vol.72 (6), p.1159-1169

2020

Volltextzugriff (PDF)

Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis

Hepatology (Baltimore, Md.), 2015-09, Vol.62 (3), p.851-862

2015

Volltextzugriff (PDF)

MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer

Clinical cancer research, 2012-02, Vol.18 (3), p.737-747

2012

Volltextzugriff (PDF)

Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats

Hepatology (Baltimore, Md.), 2015-01, Vol.61 (1), p.249-259

2015

Volltextzugriff (PDF)

The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival

Journal of hepatology, 2016-04, Vol.64 (4), p.891-898

2016

Volltextzugriff (PDF)

Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

Clinical cancer research, 2021-06, Vol.27 (11), p.3126-3140

2021

Volltextzugriff (PDF)

The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met

Nature (London), 2002-03, Vol.416 (6877), p.187-190

2002

Volltextzugriff (PDF)

The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments

Molecular biology of the cell, 2013-01, Vol.24 (2), p.129-144

2013

Volltextzugriff (PDF)

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

Oncotarget, 2015-02, Vol.6 (4), p.2315-2330

2015

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Humans
(25)
Animals
(13)
Oncology
(12)
Female
(11)
Tumors
(9)
Male
(8)
Biological And Medical Sciences
(7)
Cell Biology
(6)
Gastroenterology & Hepatology
(6)
Mice
(6)
Middle Aged
(6)
Antineoplastic Agents - Pharmacology
(5)
Breast Cancer
(5)
Cell Line, Tumor
(5)
Medical Sciences
(5)
Medicine
(5)
Monoclonal Antibodies
(5)
Pharmacology & Pharmacy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)

MicroRNAs Impair MET-Mediated Invasive Growth

Multitarget drugs: the present and the future of cancer therapy

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

TGFα expression impairs Trastuzumab-induced HER2 downregulation

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage

Genome editing of a recalcitrant wine grape genotype by lipofectamine‐mediated delivery of CRISPR/Cas9 ribonucleoproteins to protoplasts

The SH3 Domains of Endophilin and Amphiphysin Bind to the Proline-rich Region of Synaptojanin 1 at Distinct Sites That Display an Unconventional Binding Specificity

Nrf2, but not [beta]-catenin, mutation represents an early event in rat hepatocarcinogenesis

Identification of a subpopulation of patients with gastric cancer responsive to PARP inhibitors

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis

MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer

Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival

Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met

The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

Suchergebnisse filtern